Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Vanda Pharmaceuticals Inc patents


Recent patent applications related to Vanda Pharmaceuticals Inc. Vanda Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Vanda Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Vanda Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "V" | Vanda Pharmaceuticals Inc-related inventors


Metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

Isolated metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]-methyl]propanamide, methods for their use, and compositions containing the metabolites.. . ... Vanda Pharmaceuticals Inc

Treatment of circadian rhythm disorders

Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.. . ... Vanda Pharmaceuticals Inc

Iloperidone for the treatment of schizophrenia

Aspects of the invention relate generally to the treatment of schizophrenia in an individual and, more specifically, to the treatment of an individual with iloperidone, an iloperidone metabolite, or a pharmaceutically-acceptable salt thereof. In one embodiment, the invention provides a method of preventing schizophrenic relapse in an individual diagnosed with schizophrenia, the method comprising: administering to the individual iloperidone, an iloperidone metabolite, or a pharmaceutically-acceptable salt thereof at a daily dose between about 12 mg and about 16 mg following a period in which the individual's schizophrenia was stabilized.. ... Vanda Pharmaceuticals Inc

Method of predicting a predisposition to qt prolongation

The present invention describes an association between genetic polymorphisms in the abcc2 gene and a predisposition to prolongation of the qt interval, and provides related methods for the prediction of such a predisposition, the administration of qt interval-prolonging compounds to individuals having such a predisposition, and determining whether a compound is capable of inducing qt prolongation.. . ... Vanda Pharmaceuticals Inc

Method of predicting a predisposition to qt prolongation

The present invention describes an association between genetic polymorphisms in the bai3 gene and a predisposition to prolongation of the qt interval, and provides related methods for the prediction of such a predisposition, the administration of qt interval-prolonging compounds to individuals having such a predisposition, and determining whether a compound is capable of inducing qt prolongation.. . ... Vanda Pharmaceuticals Inc

Method of predicting a predisposition to qt prolongation

The present invention describes an association between genetic polymorphisms in the fam13a1 (family with sequence similarity 13, member a1) gene and a predisposition to prolongation of the qt interval, and provides related methods for the prediction of such a predisposition, the administration of qt interval-prolonging compounds to individuals having such a predisposition, and determining whether a compound is capable of inducing qt prolongation.. . ... Vanda Pharmaceuticals Inc

Method of treatment based on polymorphisms of the kcnq1 gene

The invention provides methods for the administration of compounds capable of prolonging a qtc interval and methods for predicting whether an individual is predisposed to such qtc prolongation.. . ... Vanda Pharmaceuticals Inc

Treatment of circadian rhythm disorders

Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.. . ... Vanda Pharmaceuticals Inc

Method of treatment

Embodiments of the invention relate to the treatment of sleep disturbances in individuals with smith-magenis syndrome (sms).. . ... Vanda Pharmaceuticals Inc

Highly purifid pharmaceutical grade tasimelteon

A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under gmp conditions for the presence of one or more identified impurities.. . ... Vanda Pharmaceuticals Inc

Metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

Isolated metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]-methyl]propanamide, methods for their use, and compositions containing the metabolites.. . ... Vanda Pharmaceuticals Inc

Treatment of schizophrenia

Aspects of the invention relate generally to the treatment of schizophrenia and to monitoring for specific adverse reactions.. . ... Vanda Pharmaceuticals Inc

Method of treatment

Embodiments of the invention relate generally to increasing adult height in individuals with no light perception (nlp).. . ... Vanda Pharmaceuticals Inc

Benzisoxazoles

The present invention relates to novel fatty acid esters of the reversible iloperidone metabolite p-88-8991, their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them.. . ... Vanda Pharmaceuticals Inc

04/13/17 / #20170100366

Treatment of circadian rhythm disorders

Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.. . ... Vanda Pharmaceuticals Inc

03/30/17 / #20170087123

Treatment of circadian rhythm disorders

Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.. . ... Vanda Pharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Vanda Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Vanda Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###